Vitronectin receptor (α(v)β3) mediates platelet adhesion to the luminal aspect of endothelial cells: Implications for reperfusion in acute myocardial infarction

Circulation

Volumn 96, Issue 6, 1997, Pages 1809-1818

  Gawaz, Meinrad ^a   Neumann, Franz Josef ^b   Dickfeld, Timm ^b   Reininger, Armin ^b   Adelsberger, Helmut ^b   Gebhardt, Adrian ^b   Schömig, Albert ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Endothelium; Integrins; Myocardial infarction; Platelets; Reperfusion

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ENALAPRIL; FIBRINOGEN RECEPTOR; METOPROLOL; RECOMBINANT INTERLEUKIN 1BETA; THROMBIN; TICLOPIDINE; VITRONECTIN RECEPTOR;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CHO CELL; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; THROMBOCYTE ADHESION;

EID: 0030752615     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.6.1809     Document Type: Article

References (53)

1. Hearse DJ, Bolli R. Reperfusion-induced injury: manifestations, mechanisms, and clinical relevance. Trends Cardiovasc Med. 1991; 1:233-240.
2. Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994;28:1301-1311.
3. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198-205.
4. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
5. Golino P, Ashton JH, Buja LM, Taylor AL, McNatt J, Rosolowsky M, Campbell WB, Willerson JT. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo: thromboxane A2 and serotonin are possible mediators. Circulation. 1989;79:154-166.
6. Van Ijzendoorn SCD, Heemskerk JWM, Reutlingsperger PM. Interactions between endothelial cells and blood platelets. Endothelium. 1995;3:81-98.
7. Gawaz M, Neumann FJ, Ott I, Schiessler A, Schömig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 1996;93:229-237.
8. 3 (glycoprotein GPIIb-IIIa) dependent homotypic and heterotypic cell-cell interaction. J Clin Invest. 1991;88:1128-1134.
9. 3 (platelet glycoprotein IIb-IIIa). J Biol Chem. 1992;267:22211-22216.
10. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell. 1989;58:945-953.
11. 3 integrins in hemostasis and vascular biology. Thromb Haemost. 1995;74:149-155.
12. Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly Asp-directed adhesion receptor involved in attachment of fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA. 1987;84:6471-6475.
13. 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. Biochem J. 1994;304:537-542.
14. 3 for angiogenesis. Science. 1994;264:569-571.
15. Diazflores L, Gutierrez R, Varela H. Angiogenesis: an update. Histol Histopathol. 1994;103:381-386.
16. Matsuno H, Stassen JM, Vermylen J, Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
17. Choi ET, Engel L, Callow AD, Sun S, Trachtenberg J, Santoro S, Ryan US. Inhibition of neointimal hyperplasia by blocking avb3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994;19:125-134.
18. 3 integrin increases capillary hydraulic conductivity of rat lung. Circ Res. 1995;77:651-659.
19. Coller BS, Anderson K, Weisman HF. New antiplatelet agents: platelet GPIIb-IIIa antagonists. Thromb Haemost. 1995;74:302-308.
20. Woods VL, Wolff LE, Keller DM. Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. J Biol Chem. 1986;261:15242-15251.
21. Ginsberg MH, Frelinger AL, Lam SCT, Forsyth J, McMillan R. Plow EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of platelet membrane glycoprotein IIb-IIIa with conformation specific monoclonal antibodies. Blood. 1990;76:2017-2023.
22. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;70:307-315.
23. Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H. Arg-Gly-Asp constrained within cyclic pentapeptides: strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 1991;291:50-54.
24. Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ. Desintegrins and other naturally occuring antagonists of platelet fibrinogen receptors. Semin Hematol. 1994;31:289-300.
25. Jaffe EA, Nachman RL, Becker CG, Minich CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973; 52:2745-2752.
26. 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regulation. 1990;1:883-893.
27. Gawaz M, Reininger A, Neumann FJ. Platelet activation and platelet-leukocyte adhesion in symptomatic coronary artery disease. Thromb Res. 1996;83:341-349.
28. Reininger AJ, Reininger CB, Wurzinger LJ. The influence of fluid dynamics upon adhesion of ADP-stimulated human platelets to endothelial cells. Thromb Res. 1993;71:245-249.
29. Gawaz M, Ott I, Reininger A, Heinzmann U, Neumann FJ. Agglutination of isolated platelet membranes. Arterioscler Thromb Vasc Biol. 1996;16:621-627.
30. Ginsberg MH, Loftus JC. Platelet integrins. Thromb Haemost. 1995;74:352-359.
31. Zanetti A, Conforti G, Hess S, Martin-Padura I, Ghibaudi E, Preisner KT, Dejana E. Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrines on the luminal aspect of endothelial cell membrane. Blood. 1994;84: 1116-1123.
32. Dejana E, Bertocchi F, Bortolami MC, Regonesi A, Tonta A, Brviario F, Giavazzi R. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest. 1988;82: 1430-1438.
33. Lafrenie RM, Podor TJ, Buchanan MR, Orr FW. Unregulated biosynthesis and expression of endothelial cell vitronectin receptor enhances cancer cell adhesion. Cancer Res. 1992;52:2202-2208.
34. Conforti G, Dominguez-Jimenez C, Zanetti A, Gimbrone MA, Cremona O, Marchisio PC, Dejana E. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood. 1992;80:437-446.
35. Buchanan MR, Bertomeu MC, Haas TA, Orr FW, Eltringham-Smith LL. Lovalization of 13-hydroxyoctadecadienoic acid and the vitronectin receptor in human endothelial cells and endothelial cell/platelet interactions in vitro. Blood. 1993;12: 3303-3312.
36. Kaplan JE, Moon DG, Weston LK, Minnear FL, DelVecchio PJ, Shepard JM, Fenton JW. Platelets adhere to thrombin-treated endothelial cells in vitro. Am J Physiol. 1989;257:H423-H433.
37. Etingin OI, Silverstein RL, Hajjar DP. Von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA. 1993;90:5153-5156.
38. Gawaz M, Dickfeld T, Fateh-Moghadam S, Bogner C, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Int Care Med. 1997;23:379-385.
39. Neumann FJ, Ott I, Gawaz M, Richardt G, Jochum M, Holzapfel H, Schömig A. Cardiac release of cytokines and inflammatory responses during reperfusion in acute myocardial infarction. Circulation. 1995;92:748-755.
40. Gimbrone MA Jr. Vascular endothelium: Nature's blood container. In: Gimbrone MA Jr, ed. Vascular Endothelium in Hemostasis and Thrombosis. Edinburgh, UK: Churchill Livingstone; 1986:1-21.
41. Fox JEB. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinolysis. 1994;5:291-304.
42. Risau W. Differentiation of endothelium. FASEB J. 1995;9:926-933.
43. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA. 1995; 92:1505-1509.
44. Lupu C, Manduteanu I, Calb M, Ionescu M, Simionescu N, Simionescu M. Some major plasmalemma proteins of human diabetic platelets are involved in the enhanced platelet adhesion to cultured valvular endothelial cells. Platelets. 1993;4:79-84.
45. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Monoctye tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. J Clin Invest. 1995;95:2297-2303.
46. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851.
47. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 1989;69:50-178.
48. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 1994;8:929-938.
49. Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: the responsive integrin. Cell. 1991;65:359-362.
50. Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 1991;174:785-790.
51. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol. 1989;143:4015-4018.
52. Defilippi P, Silengo L, Tarone G. Regulation of adhesion receptor expression in endothelial cells. Curr Top Microbiol Immunol. 1993; 184:87-98.
53. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb-IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.